Genuity Science Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 154
Employees
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $200M
Latest Deal Amount
  • Investors
  • 9

Genuity Science General Information

Description

Developer of a global genomics platform designed to provide genomic sequence data. The company's platform offers study design, sequencing, storage and interpretation, secondary analysis and scalable analytics, enabling organizations to improve patient health using the human genome.

Contact Information

Formerly Known As
WuXiNextCODE, WuXi NextCODE Genomics USA, WuXi NextCODE
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Biotechnology
Primary Office
  • 90 Canal Street
  • Suite 120
  • Boston, MA 02114
  • United States
+1 (781) 000-0000

Genuity Science Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Genuity Science Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series C) 27-Nov-2018 $200M 00000 Completed Generating Revenue
3. Secondary Transaction - Private 00000 Completed Generating Revenue
2. Early Stage VC (Series B) 07-Sep-2017 $240M $240M Completed Generating Revenue
1. Early Stage VC (Series A) Completed Startup
To view Genuity Science’s complete valuation and funding history, request access »

Genuity Science Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a global genomics platform designed to provide genomic sequence data. The company's platform offers study d
Decision/Risk Analysis
Boston, MA
154 As of 2020
00000
00000000000 00000

000000 0

, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis n
0000000000000 00000000
San Francisco, CA
0 As of 0000
00.00
000000000 00.00

00000000

it in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
0000000000000 00000000
Cambridge, United Kingdom
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genuity Science Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nebula Genomics Venture Capital-Backed San Francisco, CA 0 00.00 000000000 00.00
000000000 Venture Capital-Backed Cambridge, United Kingdom 00 000.00 00000000000 000.00
0000000000 (000000 Venture Capital-Backed New York, NY 00 000.00 00000000000 000.00
0000000 0 Formerly VC-backed San Francisco, CA 00 000.00 0&0 000.00
000000000 Venture Capital-Backed Ann Arbor, MI 00 000.00 0000000000 0 000.00
You’re viewing 5 of 30 competitors. Get the full list »

Genuity Science Executive Team (16)

Name Title Board Seat Contact Info
Rob Brainin Chief Executive Officer & Board Member
Anne Jones Ph.D Chief Operating Officer
Hakon Gudbjartsson Ph.D Chief Informatics Officer
Jeffrey Gulcher Ph.D Co-Founder & Chief Scientific Officer
Thomas Chittenden Ph.D Chief Data Science Officer & Founding Director
You’re viewing 5 of 16 executive team members. Get the full list »

Genuity Science Board Members (7)

Name Representing Role Since
Don Vieira Genuity Science Board Member 000 0000
Dyann Heward-Mills Self Board Member & Board Advisor 000 0000
Ge Li Ph.D Self Chairman 000 0000
James Sullivan Ph.D Self Board Member 000 0000
Paul Sanders Ph.D Genuity Science Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Genuity Science Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genuity Science Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ireland Strategic Investment Fund Sovereign Wealth Fund Minority 000 0000 000000 0
Polaris Partners Venture Capital Minority 000 0000 000000 0
3W Partners Capital PE/Buyout Minority 000 0000 000000 0
Ally Bridge Group PE/Buyout Minority 000 0000 000000 0
Amgen Ventures Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Genuity Science Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 06-Feb-2019 00000 00000 00 0000 Discovery Tools (Healthcare)
00000000 00000000 27-Nov-2018 000000000000000000 Biotechnology 000 0000000
00000 21-May-2018 00000 00000 00 00000 Biotechnology
00000000 22-Apr-2015 00000 00000 00 0000 Discovery Tools (Healthcare)
Claritas Genomics 26-Jan-2015 Early Stage VC 0000 Laboratory Services (Healthcare) 000000 00000000
To view Genuity Science’s complete investments and acquisitions history, request access »

Genuity Science Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 00000000 26-Jan-2015 00000 00000 00 0000 Completed
  • 4 buyers
To view Genuity Science’s complete exits history, request access »